80 studies found for:
Gaucher Disease
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Examining the Immune Response in Patients With Gaucher Disease and Hepatitis B or C
|
||||
| 2 |
Completed
Has Results |
Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
|
||||
| 3 | Completed |
Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease
|
||||
| 4 | Completed |
Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease
|
||||
| 5 | Completed |
OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease
|
||||
| 6 | Enrolling by invitation |
Validating a New Severity Score System for Adults With Type 1 Gaucher Disease (GD1)
|
||||
| 7 | Recruiting |
Exploration of Immunity in Gaucher Disease
|
||||
| 8 | Completed |
A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
|
||||
| 9 | Completed |
A Long-Term Extension Study of AT2101 in Type 1 Gaucher Patients
|
||||
| 10 | Completed |
PEG-Glucocerebrosidase for the Treatment of Gaucher Disease
|
||||
| 11 | Completed |
An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease
|
||||
| 12 | Approved for marketing |
Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease
|
||||
| 13 |
Completed
Has Results |
A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher Disease
|
||||
| 14 |
Completed
Has Results |
Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease
|
||||
| 15 | Completed |
Effects of Enzyme Replacement in Gaucher's Disease
|
||||
| 16 | Enrolling by invitation |
Identification of Undiagnosed Gaucher Disease
|
||||
| 17 | Active, not recruiting |
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)
|
||||
| 18 | Completed |
A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.
|
||||
| 19 |
Completed
Has Results |
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
|
||||
| 20 | Enrolling by invitation |
A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease
|
† Indicates status has not been verified in more than two years
